Karrotz, Personally I am expecting a stunner of a result. Too good for big pharmas to resist. Smith & Nephew to take us for $300m, unless the sp rises more beforehand and pushes that price up.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025